Angie Giotis

558 total citations
18 papers, 418 citations indexed

About

Angie Giotis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Angie Giotis has authored 18 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Angie Giotis's work include Cancer Treatment and Pharmacology (7 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Prostate Cancer Treatment and Research (4 papers). Angie Giotis is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Prostate Cancer Treatment and Research (4 papers). Angie Giotis collaborates with scholars based in Canada, Singapore and United States. Angie Giotis's co-authors include Carlo DeAngelis, Jenna van Draanen, Jian Pang, Elizabeth Barnes, Gunita Mitera, Gregory J. Czarnota, Nadia Salvo, D. Breen, Urban Emmenegger and Edward Chow and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Supportive Care in Cancer.

In The Last Decade

Angie Giotis

17 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angie Giotis Canada 9 200 131 117 86 85 18 418
Vincenzo Ravo Italy 12 130 0.7× 113 0.9× 66 0.6× 36 0.4× 154 1.8× 42 413
Judi van Diessen Netherlands 7 201 1.0× 123 0.9× 10 0.1× 23 0.3× 287 3.4× 14 460
C. Herzog Germany 10 134 0.7× 37 0.3× 46 0.4× 80 0.9× 46 0.5× 16 546
Petra Petranović Ovčariček Switzerland 13 120 0.6× 84 0.6× 52 0.4× 14 0.2× 84 1.0× 43 572
Michael A. Samuels United States 12 41 0.2× 159 1.2× 31 0.3× 4 0.0× 141 1.7× 35 419
Xianling Liu China 10 20 0.1× 175 1.3× 94 0.8× 26 0.3× 62 0.7× 33 506
D. Ravichandran United Kingdom 17 61 0.3× 144 1.1× 50 0.4× 145 1.7× 53 0.6× 48 709
Di Li China 10 36 0.2× 64 0.5× 180 1.5× 12 0.1× 153 1.8× 57 420
Clare Beadsmoore United Kingdom 12 119 0.6× 79 0.6× 19 0.2× 4 0.0× 127 1.5× 22 378

Countries citing papers authored by Angie Giotis

Since Specialization
Citations

This map shows the geographic impact of Angie Giotis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angie Giotis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angie Giotis more than expected).

Fields of papers citing papers by Angie Giotis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angie Giotis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angie Giotis. The network helps show where Angie Giotis may publish in the future.

Co-authorship network of co-authors of Angie Giotis

This figure shows the co-authorship network connecting the top 25 collaborators of Angie Giotis. A scholar is included among the top collaborators of Angie Giotis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angie Giotis. Angie Giotis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhang, Liying, Bo Wan, Angie Giotis, et al.. (2019). Pain descriptors of taxane acute pain syndrome (TAPS) in breast cancer patients—a prospective clinical study. Supportive Care in Cancer. 28(2). 589–598. 8 indexed citations
2.
Stinson, Jordan A., Kelvin Chan, Justin Lee, et al.. (2017). Managing chemotherapy-induced nausea and vomiting in head and neck cancer patients receiving cisplatin chemotherapy with concurrent radiation. Annals of Palliative Medicine. 6(S1). S13–S20. 7 indexed citations
3.
Chiu, Nicholas, Liying Zhang, Rebecca Dent, et al.. (2017). A prospective study of docetaxel-associated pain syndrome. Supportive Care in Cancer. 26(1). 203–211. 18 indexed citations
4.
Berry, Scott R., et al.. (2016). High prevalence of potential drug-drug interactions in patients with castration-resistant prostate cancer treated with abiraterone acetate. European Journal of Clinical Pharmacology. 72(11). 1391–1399. 22 indexed citations
5.
Martínez, María Carmen Riesco, Scott Berry, Yoo‐Joung Ko, et al.. (2016). Cost-Effectiveness Analysis of Different Sequences of the Use of Epidermal Growth Factor Receptor Inhibitors for Wild-Type KRAS Unresectable Metastatic Colorectal Cancer. Journal of Oncology Practice. 12(6). e710–e723. 16 indexed citations
6.
Rowbottom, Leigha, Jordan A. Stinson, Rachel McDonald, et al.. (2015). Retrospective review of the incidence of monitoring blood glucose levels in patients receiving corticosteroids with systemic anticancer therapy.. PubMed. 4(2). 70–7. 20 indexed citations
7.
Berry, Scott R., et al.. (2015). Characterizing the risk of drug-drug interactions in patients receiving enzalutamide for castration-resistant prostate cancer.. Journal of Clinical Oncology. 33(7_suppl). 261–261. 2 indexed citations
8.
Berry, Scott R., et al.. (2015). Drug-drug interactions in patients with castration-resistant prostate cancer undergoing abiraterone therapy: Characterizing the scale of the problem.. Journal of Clinical Oncology. 33(7_suppl). 269–269. 1 indexed citations
9.
Gandhi, Sonal, et al.. (2015). Oral Anticancer Medication Adherence, Toxicity Reporting, and Counseling: A Study Comparing Health Care Providers and Patients. Journal of Oncology Practice. 11(6). 498–504. 13 indexed citations
10.
11.
Lechner, Breanne, Carlo DeAngelis, Urban Emmenegger, et al.. (2014). The effects of denosumab on calcium profiles in advanced cancer patients with bone metastases. Supportive Care in Cancer. 22(7). 1765–1771. 22 indexed citations
12.
Feld, Jordan J., Lisa K. Hicks, Joshua Juan, et al.. (2014). An electronic prompt prior to myelosuppressive therapy to improve hepatitis B virus screening.. Journal of Clinical Oncology. 32(15_suppl). 6627–6627. 1 indexed citations
13.
Martínez, María Carmen Riesco, Scott R. Berry, Yoo‐Joung Ko, et al.. (2013). Cost-effective analysis of the use of EGFR inhibitors (E) for wild-type (WT) KRAS unresectable metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 31(15_suppl). 6552–6552. 3 indexed citations
14.
Hird, Amanda, et al.. (2013). Baseline Blood Work Before Initiation of Chemotherapy: What Is Safe in the Real World?. Journal of Oncology Practice. 9(5). e182–e185. 9 indexed citations
15.
Giotis, Angie, Mark Pasetka, Pierre K. Isogai, et al.. (2012). Severe zoledronic acid (ZOL)-associated hypophosphatemia and prognosis in patients with castration-resistant prostate cancer (CRPC).. Journal of Clinical Oncology. 30(15_suppl). e15180–e15180. 1 indexed citations
16.
Salvo, Nadia, Elizabeth Barnes, Jenna van Draanen, et al.. (2010). Prophylaxis and Management of Acute Radiation-Induced Skin Reactions: A Systematic Review of the Literature. Current Oncology. 17(4). 94–112. 269 indexed citations
17.
Draanen, Jenna van, R. Dent, Mark Pasetka, et al.. (2010). Abstract P3-15-05: Muscle and Joint Symptoms in Breast Cancer Patients Receiving Taxane-Based Chemotherapy. Cancer Research. 70(24_Supplement). P3–15. 1 indexed citations
18.
Clemons, Mark, Savita Verma, Vivian Leung, et al.. (2004). Palliative chemotherapy with vinorelbine or capecitabine in women with anthracycline and taxane refractory metastatic breast cancer. Journal of Clinical Oncology. 22(14_suppl). 773–773. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026